{"id":"W2890366457","doi":"10.1200/jco.2018.36.15_suppl.e21060","title":"Real-world dose adjustment study of first-line afatinib in pts with <i>EGFR</i> mutation-positive (<i>EGFR</i>m+) advanced NSCLC.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Afatinib; Discontinuation; Tolerability; Internal medicine; Adverse effect; Incidence (geometry); Medical record; Oncology; Gefitinib; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002218753,0.0005979785,0.0009523791,0.0002638695,0.0003193887,0.0009717613,0.000581229,0.0008986515,0.002071554],"category_scores_gemma":[0.00428577,0.0005049014,0.001575352,0.0007763237,0.0005732278,0.0007915873,0.0004804799,0.001358519,0.0005281196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001261588,"about_ca_system_score_gemma":0.001003884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001352659,"about_ca_topic_score_gemma":0.001645736,"domain_scores_codex":[0.9976652,0.001569213,0.0001663559,0.0002902799,0.0002033919,0.0001056237],"domain_scores_gemma":[0.9953541,0.0008634891,0.002449591,0.0004165381,0.0002569279,0.00065934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4901905,0.03624649,0.4039589,0.001538903,0.008716894,0.000676367,0.0007799375,0.005220519,0.007834502,0.0001933506,0.002807732,0.04183589],"study_design_scores_gemma":[0.206444,0.2605185,0.5126281,0.0001227472,0.003699921,0.001683503,0.0005503995,0.005129009,0.002893553,0.0002386165,0.005921677,0.0001699112],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997296,0.0004758508,0.0003066478,0.00009329942,0.0000199029,0.0003843091,0.001017539,0.00001477296,0.0003917108],"genre_scores_gemma":[0.9973096,0.0002165255,0.0004770692,0.0001845468,0.00003301958,0.0003926435,0.001217963,0.000005872938,0.0001627312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002218753,"threshold_uncertainty_score":0.01173401,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06109458024130315,"score_gpt":0.4845399764557509,"score_spread":0.4234453962144477,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}